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Abstract The human apolipoprotein C-I1 locus exhibits gene- 
tically determined structural polymorphism in United States 
and African blacks. In the present study, we have investigated 
the effect of the apoC-I1 polymorphism on quantitative serum 
levels of total cholesterol, total high density lipoprotein (HDL) 
cholesterol, cholesterol in high density lipoprotein subfractions, 
low density lipoprotein (LDL) cholesterol, and triglycerides 
(TG) in a sample of 368 unrelated Nigerian blacks. The frequen- 
cies of the APOC-ZZ*I and APOC-ZZL2 alleles in the samples were 
0.947 and 0.053, respectively. In males, the effect of the APOC- 
N’2 allele was to lower the total serum cholesterol and LDL- 
cholesterol levels by 13.28 mg/dl and 10.55 mg/dl, respectively, 
relative to the common allele, APOC-ZZ*1. In females, the effect 
was to lower total plasma cholesterol by 4.49 mg/dl and LDL- 
cholesterol by 3.21 mg/dl. The effect of apoC-I1 on quantitative 
lipoprotein levels is shown to be independent of variation at the 
linked apoE locus, but the products of the two loci interact in de- 
termining overall quantitative phenotypes. - Sepehrnia, B., 
M. I. Kamboh, L. L. Adams-Campbell, C. H. Bunker, M. 
Nwankwo, P. P. Majumder, and R.~ E. Ferrell. Genetic studies 
of human apolipoproteins. XI. The effect of the apolipoprotein 
C-I1 polymorphism on lipoprotein levels in Nigerian blacks. J.  
Lipid &J. 1989. 30: 1349-1355. 
Supplementary key words isoelectric focusing immunoblotting 
Apolipoproteins are the protein components of the 
plasma lipoproteins. They play an important role in lipid 
metabolism in the transport of lipids in the plasma, as re- 
cognition molecules in the receptor-mediated transport of 
lipids across plasma membranes, and as allosteric affec- 
tors of enzymes of lipid metabolism. Apolipoprotein C-I1 
(apoC-11) is a constituent of chylomicrons, very low densi- 
ty lipoproteins (VLDL), and high density lipoproteins 
(HDL). Human apoC-11 is a single polypeptide chain of 
79 amino acid residues and an estimated molecular 
weight of 8,900 (1). Mature apoC-I1 acts as an obligate ac- 
tivator of lipoprotein lipase (LPL) which catalyzes the hy- 
drolysis of triglycerides in chylomicrons and VLDL. The 
cofactor activity of apoC-I1 for LPL has been established 
in patients with genetically determined deficiency of 
apoC-11, who are severely hypertriglyceridemic, and have 
a functional deficiency of LPL (2). It has been shown that 
the enzyme LPL interacts with the COOH-terminal amino 
acid residues 56-79 (3) of apoC-11. Residues 44-55 pos- 
sess phospholipid-binding activity that enhances LPL ac- 
tivation in the presence of phospholipid. Deletion of 
residues 77-79 abolishes the ability of the COOH-termi- 
nal fragment to activate LPL and it has been suggested 
that the two COOH-terminal glutamic acid residues are 
involved in ionic interaction between LPL and apoC-I1 
(3). The apoC-I1 gene has been cloned and mapped to the 
apoC-I/C-WE linkage group on human chromosome 19 
(4). Humphries et al. (5) have used a cDNA clone for 
apoC-I1 to study two families with apoC-I1 deficiency and 
found no evidence of deletion or rearrangement of the 
apoC-I1 gene in these families. Restriction fragment length 
polymorphisms have been identified in the apoC-11 ‘region, 
but detailed studies of their possible association with disor- 
d e n  of lipid metabolism are limited. 
Menzel et al. (6) first reported a protein polymorphism 
in apoC-I1 in U.S. blacks. This polymorphism involved 
the substitution of glutamine for lysine at residue 55 of the 
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apoC-I1 polypeptide chain. They reported a phenotype 
frequency of 12% for this variant in a sample of 50 nor- 
molipemic U.S. blacks. Sepehrnia, Kamboh, and Ferrell 
(7) confirmed the presence of this polymorphism in U.S. 
blacks and further demonstrated its presence in Nigerian 
blacks, and established its autosomal codominant pattern 
of segregation in families. This study presents a detailed 
analysis of the effect of the apoC-I1 polymorphism on 
quantitative variation in serum lipids and lipoproteins of 
368 unrelated, normal individuals from Benin City, Nige- 
ria. 
MATERIALS AND METHODS 
Materials 
Acrylamide and bis acrylamide were purchased from 
Bio-Rad Laboratories (Richmond, CA). Pharmalites pH 
4-6.5 were from Pharmacia (Uppsala, Sweden), and Am- 
pholine pH 3.5-5.0 was from LKB (Bromma, Sweden). 
Nitrocellulose was obtained from Schleicher & Schd  (Keene, 
NH). Goat anti-human apoC-I1 antiserum was purchased 
from Daiichi Chemicals (Tokyo, Japan); alkaline phospha- 
tase-conjugated rabbit anti-goat IgG was from Pel-Freeze 
(Rogers, AR), and ultrapure urea was from Bethesda Re- 
search Laboratories (Gaithersburg, MD). All other chemi- 
cals were reagent grade. 
Samples 
The Nigerian population sample consisted of two 
groups. The first group (n = 172) were medical students, 
nursing students, and mid-wifery students at the Univer- 
sity of Benin, Benin City. The second group was a ran- 
dom sample of civil servants and teachers from the Oroyo 
College Secondary School, Benin City (n = 196). The 
total sample contained 368 unrelated subjects (193 males; 
175 females) with an average height and weight of 
168 f 7.6 cm and 62.95 k 9.4 kg in males and 159 + 
6.2 cm and 57.9 k 9.9 kg in females. The age range was 
from 17 to 54 years with an average age of 29.80 years. A 
detailed description of the study population has been pub- 
lished elsewhere (8). 
All individuals were fasted at the time of blood samp- 
ling. Venous blood samples were drawn into siliconized 
glass tubes. The blood samples were kept at room temper- 
ature for 2 h. Then the samples were centrifuged and se- 
rum was pipetted into glass tubes and frozen at - 47OC 
for 2 weeks. A Styrofoam ice chest with frozen cold packs 
was used to transport samples from Nigeria to Pittsburgh. 
Total serum cholesterol (E) and triglycerides (E) were 
measured manually using an enzymatic method (9,lO). 
TC and total HDL cholesterol (HDL-C) were determined 
by heparin-manganese chloride precipitation methods, 
whereas subfraction HDL3 cholesterol (HDL3-C) concen- 
tration was measured after the precipitation of HDL, 
cholesterol (HDL,-C) subfraction by dextran sulfate 
(11,lZ). LDL cholesterol (LDL-C) was calculated using 
the equation of Friedewald, Levy, and Fredrickson (13). 
A 2-ml aliquot of serum from each individual was 
transferred to the Human Genetics Laboratory and 
stored at -8OOC prior to being typed. 
Isoelectric focusing 
Thin-layer polyacrylamide gels (5%: monomer 4.85 %, 
bis 0.15%) containing 6 M urea were prepared as follows: 
10.8 g urea was dissolved in 5 ml monomer (29.1% w/v), 
5 ml bis (0.9% w/v) and the final volume was adjusted to 
30 ml with deionized water (7). The pH gradient was gen- 
erated by 1% (w/v) ampholyte concentration, pH 4-6.5. 
The polymerization agent, 20 pl of a 0.1% riboflavin solu- 
tion, was added to the acrylamide solution with constant 
stirring, then poured between two glass plates (122 x 260 
mm) separated by a 0.5-mm plastic gasket. Polymeriza- 
tion was achieved by continuous overnight exposure to 
fluorescent light. 
The gel was loaded with serum samples absorbed on 
5 x 4 mm Whatman 3 M M  filter wicks placed 1 cm from 
the cathode. Electrode strips were saturated with 1 M 
H,PO, for the anode and 1 M NaOH for the cathode. 
The gel was placed into an LKB 2217 Ultrophor electrofo- 
cusing unit connected with a Lauda RM6 cooling unit 
operating at 10-13OC and an LKB powere supply. After 
20 min focusing, the sample wicks were removed and the 
cathode electrode was blotted with filter paper. The total 
isoelectric focusing time was 3 h. 
Immunoblotting 
After isoelectric focusing was completed, a 24 x 8.5 
cm nitrocellulose membrane of 0.2 pm pore size, presoaked 
in TBS buffer (0.25 M NaCl; 0.03 M Tris-HC1, pH 8.0), 
was placed on the gel for 45 min as described by Kamboh 
and Ferrell(l4). After the passive transfer of proteins, un- 
occupied protein-binding sites were blocked by exposure 
to 5% (wh) nonfat powdered milk in deionized water for 
45 min. The membrane was then incubated for 45 min 
with 50 ml TBS solution containing 100 pl of goat 
anti-human apoC-I1 antiserum followed by 3 10-min 
washings in TBS buffer. Following the washing steps, the 
membrane was exposed to 50 ml TBS solution containing 
10 pl rabbit anti-goat IgG conjugated with alkaline phos- 
phatase, for 45 min, followed by 3 10-min washings in 
TBS buffer. Finally, the membrane was stained for alka- 
line phosphatase using 20 mg 0-naphthylphosphate, 20 
mg Fast Blue BB salt, and 50 mg magnesium sulfate in 
50 ml of buffer (1.8 g NaOH, 3.7 g boric acidlliter). 
Statistical methods 
Allele frequencies were estimated by gene counting. A 
contingency chi-square test was used to test for homogeneity 
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between the two population samples. For each lipid and 
lipoprotein variable, adjustments were done to remove the 
effects of concomitant variables which were: age, age2, 
height, height', weight, and body mass index [BMI]. The 
adjustment was perfomed in two steps. First, significant 
concomitant variables were identified by stepwise regres- 
sion analysis. Second, the multiple regression equation 
using the significant concomitant variables was estimated 
for each lipid and lipoprotein variable, and was used to 
compute the residuals (i.e., the adjusted values of the vari- 
able). 
The adjusted lipid and lipoprotein variables were then 
examined for closeness to the normal distribution by com- 
puting skewness and kurtosis coefficients. Suitable trans- 
formations of the adjusted variables were performed to 
induce normality to the extent possible. 
To test whether the mean lipidllipoprotein profiles were 
equal between sexes and among apoC-I1 phenotypes, a 
multivariate analysis of variance was performed by consid- 
ering jointly the vectors of mean values of the lipidflipopro- 
tein variables. 
Analyses of variance were used to test differences in 
mean values of adjusted variables between sexes and/or 
among apoC-I1 phenotypes. The standard statistical anal- 
yses were performed using SAS, BMDP, and MINITAB 
program packages. Computational formulae used for the 
average excess of the apoC-I1 allele have been given else- 
where (15). 
RESULrj  
The phenotype and allele frequency distribution of 
apoC-I1 in male and female Nigerians is presented in 
Table 1. Both sexes show comparable apoC-I1 values and 
no significant departure from Hardy-Weinberg equili- 
brium was detected in either sex. Stepwise regression anal- 
yses were performed on each quantitative variable to iden- 
tify significant concomitant variables. Age and [BMI] were 
found to be the two most important concomitant variables. 
After adjustment for the effects of these two concomitant 
TABLE 1. Distribution of common apoC-I1 phenotypes and allele 
frequencies in Nigerian males and females 
Phenotypes Allele Frequencies 
Number 
Sex Tested 1-1 2-1 2-2 APO C-Il'l APO C-11.2 
Male 193 173 18 2 0.943 0.057 
Female 175 158 17 0 0.951 0.049 
Pooled 368 331 35 2 0.947 0.053 
variables, the effects of the other concomitant variables 
were not significant. The multiple linear regression equa- 
tions obtained from the stepwise regression analyses were 
then used for adjusting the values of lipid variables of in- 
terest. 
The adjusted mean values of all serum lipid variables 
are given in Table 2 .  Note that the average adjusted TC 
and LDL-C among individuals with apoC-I1 2-1 pheno- 
type are, respectively, 12.13 mg/dl and 9.66 mg/dl lower 
than the average adjusted values of individuals of the 
apoC-I1 1-1 phenotype. The differences are significant at 
the 5% level. The differences for the other quantitative 
lipoprotein variables between 1-1 and 2-1 phenotypes are 
not statistically significant. (The 2-2 phenotype was ex- 
cluded from these comparisons because of small sample 
size, 2 out of 368 individuals). 
A two-way analysis of variance was performed separate- 
ly for each lipid variable to test whether the adjusted 
mean values of lipid variables differed significantly be- 
tween sexes and/or among apoC-I1 phenotypes. However, 
prior to performing the analyses of variance, the skewness 
and kurtosis coefficients of the adjusted lipid variables 
were computed. The adjusted values were also transformed 
logarithmically and the skewness and kurtosis coefficients 
of the transformed values were also computed to find out 
whether a logarithmic transformation resulted in bringing 
the distribution closer to the normal distribution. The log- 
arithmic transformation was useful for HDL-C, HDL3-C, 
and TG, but not for TC and LDL-C. Two-way analyses 
of variances were, therefore, performed on the untrans- 
formed adjusted values of TC and LDL-C and on the 
TABLE 2. Adiusted mean values of serum lipid variables in the sample of 368 Nigerian Blacks 
ApoC-I1 Phenotype 
Lipid 
Variable 2-2 2- 1 1-1 Pooled Mean 
mg/dl f SE" 
TC 145.61 * 11.03 150.32 f 1.84 162.45 f 0.07 161.21 f 1.82 
35.82 i 7.65 44.30 f 0.39 47.02 fr 0.02 46.64 f 0.61 
HDLS-C 22.06 * 5.55 28.37 f 0.26 30.12 f 0.00 29.91 i 0.38 
LDL-C 95.56 f 3.81 92.29 f 1.46 101.95 f 0.05 100.96 f 1.67 
TG 75.06 f 4.99 68.76 f 1.19 67.94 * 0.00 68.06 f 1.64 
HDL-C 
"Adjusted mean value is unadjusted grand mean plus mean of the adjusted residual. 
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log,, transformed values of HDL-C, HDL3-C, and TG. 
The analysis of variance models included sex and apoC-I1 
phenotype as the main effects and also the interaction be- 
tween the two. For each variable, the analysis was per- 
formed including and excluding individuals of the 
apoC-112-2 phenotype because the number of individuals 
with the 2-2 phenotype was small. 
For purposes of testing the significance of the main and 
interaction effects, we first performed a multivariate anal- 
ysis of variance using the mean vectors of the lipid varia- 
bles. The Wilks’ A values were computed and the corre- 
sponding approximate F-ratios (16) are given in the first 
row of Table 3. It is seen that while the difference between 
sexes is significant, the differences among apoC-I1 pheno- 
types are not significant. We have also performed univar- 
iate analysis of variance for each of the lipid variables 
separately (Table 3). It is seen that neither of the main 
effects is significant for HDL-C or HDL3-C. Only the 
effect of sex is significant for TG, while the effects of both 
sex and phenotype are significant for X and LDL-C. 
However, it should be noted that the effect of phenotype 
was significant only when individuals of the 2-2 pheno- 
type were excluded. We attribute this effect to the small 
number of apoC-I1 2-2 individuals (2/368). The interac- 
tion effects are nonsignificant for all variables. Because of 
the significant differences between sexes, separate ad- 
justed mean lipid values were computed for males and fe- 
males (Table 4). 
We estimated the effects of the apoC-I1 polymorphism 
on TC, LDL-C, and TG levels separately for each sex 
(Table 5). The average excesses of the APOC-II*2 allele 
on TC and LDL-C are - 13.28 mg/dl and - 10.55 mg/dl, 
respectively, in males. In females, the average excess of 
APOC-ZZ*2 allele on IC is - 4.49 mg/dl and on LDL-C 
is - 8.33 mg/dl. In the pooled sample the average excess 
of the APOC-ZZ*2 allele on TC is - 11.37 mg/dl and on 
LDL-C is - 8.33. The average excess of the common al- 
lele, APOC-ZZ*l, on either X or LDL-C is negligible in 
the pooled sample as also in both sexes. Although the ef- 
fect of phenotype was nonsignificant for TG, the effect of 
sex was significant, therefore we computed the average ex- 
cesses of the alleles on TG. While among males the aver- 
age excess of both alleles was negligible, among females 
the average excess of APOC-ZZ*2 was 4.35 mg/dl. 
A complem,entary DNA probe and somatic cell hybrids 
have been used to map the apoC-I1 gene to human chro- 
mosome 19 (4,17). Family studies using apoE protein 
polymorphism and RFLP alleles near the apoC-I1 gene 
show that the apoC-I1 and apoE loci are closely linked 
(18). Linkage disequilibrium has also been reported be- 
tween the apoE and apoC-I1 loci (18J9). Because the alle- 
lic effect of the APOC-ZZ*2 allele is similar to that reported 
for the APOE*2 allele, we wished to rule out the possibili- 
ty that strong disequilibrium between these loci was re- 
sponsible for the estimated effects. We have examined the 
extent of linkage disequilibrium between the apoE and 
apoC-I1 loci in our data using Bennett’s (20) estimation 
procedure. The apoE phenotypes were determined on the 
sample of 369 individuals by the method of Kamboh, Fer- 
rell, and Kottke (21). The maximum likelihood estimate 
of the coefficient of linkage disequilibrium, D, in the pre- 
sent data set turns out to be D = - 0.0056. The value of 
In-likelihood at D is -614.91. At D = 0, the value of 
In-likelihood is - 615.77. The xz value (with 1 d.f) for test- 
TABLE 3. Two-way analysis of variance for testing significances and the effects of sex, apoC-I1 phenotype, 
and interaction between sex and phenotype 
F-Ratio for Effect of 
Gender Phenotype Gender X Phenotype 
Including Excluding Including Excluding Excluding 
2-2 2-2 2-2 2-2 2-2 
Lipid Variable Phenotype Phenotype Phenotype Phenotype Phenotype 
All (multivariate)“ 12.08’ 
(5,360)’ 
TC 9.99’ 
(1,364) 
(1,364) 
(1,364) 
(1,364) 
(1,364) 
HDL-C 1.48 
HDLS-C 0.50 
LDL-C 9.83’ 
TG 8.30’ 
11.98’ 
9.69’ 
1.25 
0.67 
(5,358) 
(1,362) 
(1,362) 
(1,362) 
9.73’ 
(1,362) 
(1,362) 
8.25’ 
0.90 
(10,720) 
2. 58’ 
(2,364) 
1.86 
(2,364) 
2.17 
(2,364) 
1.74 
(2,364) 
0.12 
(2,364) 
1.23 
4.65’ 
1.87 
1.91 
(1,362) 
3.41’ 
(1,362) 
0.14 
(1,362) 
(5,358) 
(1,362) 
(1,362) 
“F-ratios for the multivariate test are approximate. 
’Significant at 5% level. 
‘Figures in parentheses indicate degrees of freedom 
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TABLE 4. Adjusted mean values of serum lipid variables in the sample of Nigerian black 
males (n = 193) and females (n = 175) 
ApoC-I1 Phenotype 
1-1 2-1 2-2 
Lipid (Male = 173) (Male = 18) (Male = 2) 
Variable Sex (Female - 158) (Female = 17) (Female - 0) Pooled Mean 
TC Male 
HDL-C Male 
HDLS-C Male 
LDL-C Male 
TG Male 
Female 
Female 
Female 
Female 
Female 
160.80 f 2.35 
164.05 * 2.63 
46.13 i 0.89 
47.92 f 0.91 
30.87 f 0.58 
29.29 f 0.53 
99.27 i 2.25 
104.65 i 2.33 
76.99 i 2.35 
57.86 f 1.81 
mg/dl + SE" 
143.34 i 6.03 150.83 i 2.65 
159.03 f 6.09 
36.41 + 2.92 43.38 * 3.09 
44.61 * 2.07 
29.37 i 1.82 22.31 i 0.68 
27.43 + 1.87 
84.85 i 5.33 98.69 * 5.99 
101.06 f 6.44 
75.50 * 6.12 78.61 f 31.31 
62.68 + 5.09 
159.07 f 2.57 
163.56 f 2.60 
45.77 * 0.86 
47.60 f 0.85 
30.64 * 0.55 
29.11 f 0.52 
97.92 * 2.35 
104.30 f 2.37 
76.87 + 2.50 
58.33 i 1.81 
"Adjusted mean value in unadjusted males and females grand mean of the adjusted residual 
ing the significance of difference between these likelihood 
values is 1.716, which is not significant at the 5% level. In 
other words, we conclude that there is no evidence of sig- 
nificant linkage disequilibrium between the apoE and the 
apoC-I1 loci in the present data set. Thus, the detected 
effect of the apoC-I1 polymorphism on cholesterol and tri- 
glyceride levels in this sample is not due to the linkage dis- 
equilibrium of this locus with the apoE locus. 
DISCUSSION 
Polymorphism of apoC-I1 in blacks was first suggested 
by Menzel et al. (6). They showed that this variation was 
due to the substitution of glutamine for lysine at residue 
55 of the apoC-I1 polypeptide chain. Comparison of the 
isoprotein pattern and allele frequency in US. and Afri- 
can blacks (7) convinced us that variant allele characterized 
by Menzel et al. (6) and the APOC-ZZ*Z allele observed in 
Nigerians are identical. The biochemical findings already 
discussed (1,3) suggest that an amino acid substitution at 
residue 55 might have an impact on phospholipid bind- 
ing, LPL activation, or both. In this study we have found 
that individuals heterozygous for APOC-ZI*Z allele have 
lower total cholesterol and LDL-C levels, and increased 
TG levels. 
Menzel et al. (6) reported that there is no significant 
effect of the apoC-I1 2-1 phenotype on quantitative levels 
of lipids and lipoproteins in a sample of 50 U.S. blacks. 
These apparent differences may be due to two factors. 
First, the sample size in Menzel et al. (6) was perhaps too 
small (44 subjects with the apoC-I1 1-1 phenotype and 6 
subjects with apoC-I1 2-1 phenotype) to allow the detec- 
tion of the effect of the apoC-I1 polymorphism on lipid 
levels. Second, the most important factor is that the lipid 
and lipoprotein variables in Menzel et al. (6) were not ad- 
justed for concomitant variables that may have obscured 
the phenotype effect. A paired t-test was performed to test 
for significant differences between the unadjusted lipid 
and lipoprotein levels for apoC-I1 1-1 and apoC-I1 2-1 in- 
dividuals in U.S. blacks (Menzel's study) and Nigerian 
blacks (this study). Table 6 shows that TC, LDL-C, 
HDL-C, and TG levels are significantly different in apoC- 
I1 1-1 individuals for the two populations. In apoC-I1 2-1 
individuals, only lT and HDL-C are significantly 
different for US. blacks and Nigerian blacks. These re- 
TABLE 5. Average excess of the apoC-I1 alleles on TC, LDL-C, and TG in Nigerian males and females 
Male Female Pooled 
A POC-II.1 APOC-II *2 A POC-II. I APOC-IIY' APOC-II'I APOC-11'2 
mg/dl 
TC 0.87 - 13.28 0.23 - 4.49 0.63 - 11.37 
LDL-C 0.64 - 10.55 0.17 - 3.21 0.50 - 8.33 
TG 0.05 - 0.80 - 0.22 4.35 - 0.08 1.34 
Sepehmia et al. ApoC-I1 polymorphism and lipoprotein levels 1353 
 by guest, on Novem
ber 20, 2010
w
w
w
.jlr.org
D
ow
nloaded from
 
TABLE 6.  Comparison of unadjusted lipid and lipoprotein levels ( * SD) in United States blacks 
(data from 6) and Nigerian blacks for apoC-I1 1 - 1  and apoC-I1 2-1 phenotypes 
ApoC-I1 
Population N U .  Phenotype TC LDL-C HDL-C TG 
mg/dl 
U . S . blacks 44 1 - 1  199 f 36 1 1 1  f 33 62 * 14 90 f 84 
Nigerian blacks 331 1 - 1  162 * 35 101 i 32 46 f 1 1  67 f 31 
(6.42)" (1.89)" (3.3 1 )" (1.80)" 
U.S. blacks 6 2- 1 189 f 32 106 f 27 62 i 13 92 f 49 
Nigerian blacks 35 2-1 154 32 95 f 29 44 f 12 72 f 26 
(2.47)" (0.91) (3.17)" (0.98) 
Values in parentheses are f-test values 
"Significant at 5% level. 
sults indicate that despite the shared African ancestry of 
these populations, differences in cultural practices and/or 
dietary habits have a significant influence on lipid and 
lipoprotein levels. It is known that the Nigerian blacks use 
little animal fat but have a diet high in saturated fat derived 
from palm oil. 
Studies on the apoE polymorphism in Nigerian blacks 
(22) and U.S. blacks (23) demonstrate that the frequency of 
the APOE*4 allele is significantly higher in blacks than in 
other reported ethnic groups. The effect of the APOE*4 
allele in all the reported populations, including Nigerian 
blacks, is to raise X and to lower TG. We assigned 35 in- 
dividuals of the apoC-112-1 phenotype with their correspon- 
ding apoE phenotypes (Table 7), and then estimated the 
average effects of apoE polymorphism on these subsamples. 
The results show that the effect of the APOE*4 allele in in- 
dividuals carrying the APOC-II*2 allele is to lower the total 
cholesterol and LDL-C by 4.70 mg/dl and 1.76 mg/dl, re- 
spectively. This effect is significantly different from the aver- 
age excess of the APOE *4 allele in the total Nigerian sample, 
where the APOE*4 allele was found to raise total cholesterol 
and LDL-C by 6.15 mg/dl and 6.77 mg/dl, respectively (22). 
These differences indicate that there is an interaction between 
alleles at the apoE and a@-I1 loci in determining the 
overall cholesterol levels in Nigerians. Unfortunately, we did 
not observe any individuals carrying both the APOE *2 and 
APOC-IZ*2 alleles to estimate the simultaneous effect of 
these two alleles, both of which are associated with low cho- 
lesterol and high triglyceride levels. However, on the basis 
TABLE 7 .  The apoC-I1 phenotypes and corresponding apoE 
phenotypes in 337 Nigerian blacks 
ApoC-I1 Phenotype 
ApoE 
Phenotype 1 - 1  2-1 2-2 Total 
3-3 150 21 2 173 
4-3 112 12 0 124 
4-4 38 2 0 40 
Total 300 35 2 337 
of our observation of the simultaneous effect of the APOE*4 
and APOC-ZIL2 alleles we would predict that the combined 
effect of the APOE*2 and APOC-II*2 alleles would result in 
an additive decrease in total cholesterol levels. It is postu- 
lated that the presence of the APOC-II*2 allele in conjunc- 
tion with E 3-2 phenotype may mimic the quantitative 
effects seen in apoE 2-2 homozygotes, because of cumulative 
single gene dose effects contributed by the 
APOC-II*2 and APOE*2 alleles. More than 90% of patients 
with type I11 hyperlipidemia have the apoE 2-2 phenotype 
(24). However, we suggcst that individuals with E 3-2 pheno- 
types who are also carriers of the APOC-II*2 allele 
may also be susceptible to developing type I11 hyperlipidemia 
or other related hyperlipidemia phenotypes. In this context, 
Menzel et al. (6) noted in their study that all four hyperlip- 
idemic patients were double heterozygous for the E and C- 
I1 genes. The presence of the apoE 3-2 and apoC-I1 2-1 
phenotypes in all four hyperlipidemic patients is significant- 
ly different from what one would expect in normolipidemic 
individuals based on the respective frequencies of these two 
alleles in the black population. Although the number of pa- 
tients observed by Menzel et d. (6) is too small (n ='  4) for 
any conclusions to be reached, the study opens further ave- 
nues to investigate the role of the apoC-I1 locus in Type I11 
hyperlipidemia and other lipid disorders. I 
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